Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We are delighted to announce that the PROTECT-CH study has been approved for Urgent Public Health (UPH) designation. This is an important milestone for the study, and is crucial to ensuring that we continue to progress at a rapid pace.

What is UPH designation? 

In order to ensure the best use of NHS resources during the COVID-19 pandemic, the National Institute for Health Research established a process by which those delivering COVID-19 studies could apply to be prioritised as UPH research.  

To receive UPH designation, studies are assessed against the below criteria.  

  • How compelling is the science underpinning the proposed study? 
  • Is it feasible to deliver in the current environment of the NHS and social care? 
  • Is the study of appropriate scope and scale for national priority status? 
  • Is the funding appropriate to deliver the proposed outcomes of the study? 
  • Is there an appropriate management plan to avoid interference with recruitment to other UPH studies? 
  • Will results be relevant to this pandemic? 

Once approved as UPH-designated research by the Department of Health and Social Care (DHSC)the set-up and delivery of the study is prioritised by all necessary organisations across the research, health and social care systems.  

More information can be found at the following link: